Last reviewed · How we verify
Alprazolam 2 MG
At a glance
| Generic name | Alprazolam 2 MG |
|---|---|
| Also known as | CYP3A4/5 substrate, Xanax |
| Sponsor | University of Illinois at Chicago |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- An Extension Test of Whether to Use Oral Anti-anxiety Drugs (XANAX) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction (PHASE4)
- Oral vs IV Sedation for Cataract Surgery in Older Adults (PHASE4)
- Cognitive Behavioral Couple Therapy for Perinatal Distress (NA)
- A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience (PHASE1)
- A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users (PHASE1)
- Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions (PHASE1)
- Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions (PHASE1)
- An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |